Anti-Infective Drugs Global Market Report 2018 Including: Antivirals; Antibiotics; Antifungals; Others (Antihelmethic, Antiprotozoal)Covering: Gilead,Merck & Co,GlaxosmithKline,Bristol-Myers Squibb Company,Johnson & Johnson
Anti-Infective Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-infective drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
Scope
Markets Covered: Antivirals; Antibiotics; Antifungals; Others (Antihelmethic, Antiprotozoal)
Companies Mentioned: Gilead,Merck & Co,GlaxosmithKline,Bristol-Myers Squibb Company,Johnson & Johnson
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Anti-Infective Drugs Market Characteristics
- 2. Anti-Infective Drugs Market Size And Growth
- 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
- 2.1.1. Drivers Of The Market
- 2.1.2. Restraints On The Market
- 2.2. Forecast Market Growth, Value ($ Billion)
- 2.2.1. Drivers Of The Market
- 2.2.2. Restraints On The Market;
- 3. Anti-Infective Drugs Trends And Strategies;
- 4. Pestle Analysis
- 4.1. Political
- 4.2. Economic
- 4.3. Social
- 4.4. Technological
- 4.5. Legal
- 4.6. Environmental;
- 5. Anti-Infective Drugs Market Customer Information;
- 6. Anti-Infective Drugs Market Regional And Country Analysis
- 6.1. Global Anti-Infective Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
- 6.2. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Region
- 6.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
- 6.4. Global Anti-Infective Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
- 6.5. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Country
- 6.6. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
- 7. Anti-Infective Drugs Market Segmentation
- 7.1. Global Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 7.2. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 8. Anti-Infective Drugs Market Segments
- 8.1.Antivirals
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Antivirals Market, 2017, By Segment, Value ($ Billion)
- 8.2.Antibiotics
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Antibiotics Market, 2017, By Segment, Value ($ Billion)
- 8.3.Antifungals
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Antifungals Market, 2017, By Segment, Value ($ Billion)
- 8.4.Others (Antihelmethic, Antiprotozoal)
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Others (Antihelmethic, Antiprotozoal) Market, 2017, By Segment, Value ($ Billion)
- 9. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors
- 9.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
- 9.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
- 10. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries
- 10.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country
- 10.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country
- 11. Anti-Infective Drugs Market Comparison With Industry Metrics
- 11.1. Global Number Of Pharmacists, 2017, By Country
- 11.2. Global Infectious Diseases Market Revenue Versus Number Of Pharmacists, 2017, By Country
- 11.3. Global Number Of Pharma Enterprises, 2017, By Country
- 11.4. Global Infectious Diseases Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
- 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
- 11.6. Global Infectious Diseases Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
- 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
- 11.8. Global Infectious Diseases Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
- 11.9. Prevalent Cases Of Hiv, 2014, By Country
- 11.10. Global Number Of General Practitioners 2017, By Country
- 11.11. Global Infectious Diseases Market Revenue Versus Number Of General Practitioners, 2017, By Country
- 12. Asia-Pacific Anti-Infective Drugs Market
- 12.1.1. Asia-Pacific Anti-Infective Drugs Market Overview
- 12.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.1.4. Asia-Pacific Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 12.1.5. Asia-Pacific Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
- 12.3. China Anti-Infective Drugs Market
- 12.3.1. China Anti-Infective Drugs Market Overview
- 12.3.2. China Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.3.3. China Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.3.4. China Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 12.3.5. China Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.4. India Anti-Infective Drugs Market
- 12.4.1. India Anti-Infective Drugs Market Overview
- 12.4.2. India Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.4.3. India Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.4.4. India Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 12.4.5. India Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.5. Japan Anti-Infective Drugs Market
- 12.5.1. Japan Anti-Infective Drugs Market Overview
- 12.5.2. Japan Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.5.3. Japan Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.5.4. Japan Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 12.5.5. Japan Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.6. Australia Anti-Infective Drugs Market
- 12.6.1. Australia Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.6.2. Australia Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.6.3. Australia Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 12.6.4. Australia Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13. Western Europe Anti-Infective Drugs Market
- 13.1.1. Western Europe Anti-Infective Drugs Market Overview
- 13.1.2. Western Europe Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.1.4. Western Europe Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 13.1.5. Western Europe Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.2. Western Europe Anti-Infective Drugs Market: Country Analysis
- 13.3. UK Anti-Infective Drugs Market
- 13.3.1. UK Anti-Infective Drugs Market Overview
- 13.3.2. UK Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.3.3. UK Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.3.4. UK Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 13.3.5. UK Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.4. Germany Anti-Infective Drugs Market
- 13.4.1. Germany Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.4.2. Germany Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.4.3. Germany Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 13.4.4. Germany Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.5 France Anti-Infective Drugs Market
- 13.5.1 France Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.5.2 France Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.5.3. France Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 13.5.4. France Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.6. Italy Anti-Infective Drugs Market
- 13.6.1. Italy Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.6.2. Italy Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.6.3. Italy Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 13.6.4. Italy Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.7. Spain Anti-Infective Drugs Market
- 13.7.1. Spain Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.7.2. Spain Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.7.3. Spain Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 13.7.4. Spain Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 14. Eastern Europe Anti-Infective Drugs Market
- 14.1.1. Eastern Europe Anti-Infective Drugs Market Overview
- 14.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 14.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 14.1.4. Eastern Europe Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 14.1.5. Eastern Europe Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 14.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis
- 14.3. Russia Anti-Infective Drugs Market
- 14.3.1. Russia Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 14.3.2. Russia Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 14.3.3. Russia Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 14.3.4. Russia Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 15. North America Anti-Infective Drugs Market
- 15.1.1. North America Anti-Infective Drugs Market Overview
- 15.1.2. North America Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 15.1.3. North America Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 15.1.4. North America Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 15.1.5. North America Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 15.2. North America Anti-Infective Drugs Market: Country Analysis
- 15.3. USA Anti-Infective Drugs Market
- 15.3.1. USA Anti-Infective Drugs Market Overview
- 15.3.2. USA Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 15.3.3. USA Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 15.3.4. USA Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 15.3.5. USA Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 16. South America Anti-Infective Drugs Market
- 16.1.1. South America Anti-Infective Drugs Market Overview
- 16.1.2. South America Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 16.1.3. South America Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 16.1.4. South America Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 16.1.5. South America Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 16.2. South America Anti-Infective Drugs Market: Country Analysis
- 16.3. Brazil Anti-Infective Drugs Market
- 16.3.1. Brazil Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 16.3.2. Brazil Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 16.3.3. Brazil Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 16.3.4. Brazil Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 17. Middle East Anti-Infective Drugs Market
- 17.1.1. Middle East Anti-Infective Drugs Market Overview
- 17.1.2. Middle East Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 17.1.3. Middle East Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 17.1.4. Middle East Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 17.1.5. Middle East Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 18. Africa Anti-Infective Drugs Market
- 18.1.1. Africa Anti-Infective Drugs Market Overview
- 18.1.2. Africa Anti-Infective Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 18.1.3. Africa Anti-Infective Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 18.1.4. Africa Anti-Infective Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Antivirals
- Antibiotics
- Antifungals
- Others (Antihelmethic, Antiprotozoal)
- 18.1.5. Africa Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 19. Anti-Infective Drugs Market Competitive Landscape
- 19.1. Company Profiles
- 19.2. Gilead
- 19.2.1. Overview
- 19.2.2. Products And Services
- 19.2.3. Strategy
- 19.2.4. Financial Performance
- 19.3. Merck & Co
- 19.3.1. Overview
- 19.3.2. Products And Services
- 19.3.3. Strategy
- 19.3.4. Financial Performance
- 19.4. GlaxosmithKline
- 19.4.1. Overview
- 19.4.2. Products And Services
- 19.4.3. Strategy
- 19.4.4. Financial Performance
- 19.5. Bristol-Myers Squibb Company
- 19.5.1. Overview
- 19.5.2. Products And Services
- 19.5.3. Strategy
- 19.5.4. Financial Performance
- 19.6. Johnson & Johnson
- 19.6.1. Overview
- 19.6.2. Products And Services
- 19.6.3. Strategy
- 19.6.4. Financial Performance
- 20. Key Mergers And Acquisitions In The Anti-Infective Drugs Market
- 21. Market Background: Anti-Infective Drugs Market
- 21.1.1. Anti-Infective Drugs Market Characteristics
- 21.1.2. Anti-Infective Drugs Market Historic Growth, Value ($ Billion)
- 21.1.2.1. Drivers Of The Market
- 21.1.2.2. Restraints Of The Market
- 21.1.3. Anti-Infective Drugs Market Forecast Growth, Value ($ Billion)
- 21.1.3.1. Drivers Of The Market
- 21.1.3.2. Restraints Of The Market
- 21.1.4. Anti-Infective Drugs Trends And Strategies
- 21.2. Anti-Infective Drugs Market Regional And Country Analysis
- 21.2.1. Global Anti-Infective Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
- 21.2.2. Global Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Region
- 21.2.3. Anti-Infective Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
- 21.2.4. Anti-Infective Drugs Market, 2013 - 2021, Historic And Forecast, By Country
- 21.2.5. Anti-Infective Drugs Market, Growth And Market Share Comparison, By Segment
- 21.2.6. Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country And Segment
- 21.3. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors
- 21.3.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
- 21.3.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
- 21.4. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries
- 21.4.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country
- 21.4.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country
- 21.5. Key Mergers And Acquisitions In The Anti-Infective Drugs Market
- 22. Appendix
- 22.1. NAICS Definitions Of Industry Covered In This Report
- 22.2. Abbreviations
- 22.3. Currencies
- 22.4. Research Inquiries
- 22.5. The Business Research Company
- 22.6. Copyright And Disclaimer